Butterfly NetworkFRA:7JA +1.63%40 9-Day RSI is 55.59 as of Jul. 11, 2026. GuruFocus rates FRA:7JA with a GF Score™ of 40/100 and a GF Value™ of €2.00 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 869 Medical Devices & Instruments companies, Butterfly Network ranks worse than 78.48% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
The industry rank for Butterfly Network's 9-Day RSI or its related term are showing as below:
FRA:7JA's 9-Day RSI is ranked worse than 78.48% of 869
companies
in the Medical Devices & Instruments industry
Industry Median: 46.94
vs FRA:7JA: 55.59
Butterfly Network (FRA:7JA) 9-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
Butterfly Network 9-Day RSI Related Terms
FRA:7JA vs TMDX, AXGN, NEOG: 9-Day RSI Comparison
For the Medical Devices subindustry, Butterfly Network's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Butterfly Network 9-Day RSI vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Butterfly Network's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where Butterfly Network's 9-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Butterfly Network (FRA:7JA) has a 9-Day RSI of 55.59 as of Jul. 11, 2026. According to the industry distribution chart, Butterfly Network ranks #682 out of 869 companies in the Medical Devices & Instruments industry, placing it in the top 78.5%.
Is Butterfly Network's 9-Day RSI too high?
Butterfly Network's current 9-Day RSI is 55.59. The Medical Devices & Instruments industry median 9-Day RSI is 46.94. Butterfly Network's value of 55.59 is 18.4% above this industry median. Based on the distribution chart, Butterfly Network ranks #682 out of 869 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Butterfly Network has a GF Score™ of 40/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Butterfly Network's 9-Day RSI compare to TMDX and AXGN?
According to the Medical Devices & Instruments industry distribution chart, Butterfly Network ranks #682 out of 869 companies for 9-Day RSI. This places Butterfly Network in the lower half of its industry. The industry median 9-Day RSI is 46.94. Butterfly Network's value of 55.59 is 18.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Medical Devices & Instruments company?
The median 9-Day RSI among Medical Devices & Instruments companies is 46.94, based on 869 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Butterfly Network's current 9-Day RSI of 55.59 is 18.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median 9-Day RSI is 46.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Butterfly Network's current 9-Day RSI is 55.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Butterfly Network stock overvalued right now?
Based on GuruFocus' analysis, Butterfly Network (FRA:7JA) is currently considered Significantly Overvalued. The stock's GF Value™ is €2.00, compared to a current price of €7.18 — trading 259% above its estimated fair value. The current 9-Day RSI is 55.59 and 18.4% above the Medical Devices & Instruments industry median of 46.94. Butterfly Network's overall GF Score™ is 40/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For Butterfly Network (FRA:7JA), the current 9-Day RSI is 55.59 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Butterfly Network (FRA:7JA) Overvalued in 2026?
Based on GuruFocus' analysis, Butterfly Network stock appears to be overvalued.
The current stock price of €7.18 is trading 259% above its estimated GF Value™ of €2.00.
GuruFocus considers Butterfly Network to be Significantly Overvalued.
Key valuation signals for FRA:7JA:
9-Day RSI: 55.59
GF Value™: €2.00 vs. price of €7.18 (259% above fair value)
Industry Position: 18.4% above the Medical Devices & Instruments median (#682 of 869)
No single metric tells the full story. See the FRA:7JA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Butterfly Network Inc is a digital health business transforming care with handheld, whole-body ultrasound. Powered by its proprietary Ultrasound-on-Chip technology, its solution enables the acquisition of imaging information from an affordable, powerful device that fits in a healthcare professional's pocket with a combination of cloud-connected software and hardware technology that is easily accessed through a mobile application. Butterfly iQ+ is an ultrasound device that can perform whole-body imaging in a single handheld probe using semiconductor technology. The company operates in one reportable segment, which includes all activities related to the development, manufacture, and sale of the Company's products, software, and other services.
40GF Score
Get the complete analysis for FRA:7JA
9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:7JA has been successfully added to your 